标题
Cost-effectiveness of Aducanumab and Donanemab for Early Alzheimer Disease in the US
作者
关键词
-
出版物
JAMA Neurology
Volume 79, Issue 5, Pages 478
出版商
American Medical Association (AMA)
发表日期
2022-03-28
DOI
10.1001/jamaneurol.2022.0315
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Alzheimer's disease
- (2021) Philip Scheltens et al. LANCET
- Donanemab in Early Alzheimer’s Disease
- (2021) Mark A. Mintun et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evaluation of Aducanumab for Alzheimer Disease
- (2021) G. Caleb Alexander et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody
- (2021) Chad J. Swanson et al. Alzheimers Research & Therapy
- Aducanumab produced a clinically meaningful benefit in association with amyloid lowering
- (2021) Jeffrey Cummings et al. Alzheimers Research & Therapy
- Critical Appraisal of Amyloid Lowering Agents in AD
- (2021) Boris Decourt et al. Current Neurology and Neuroscience Reports
- Will CMS Find Aducanumab Reasonable and Necessary for Alzheimer Disease After FDA Approval?
- (2021) Kevin A. Schulman et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Prescribing Aducanumab in the Face of Meager Efficacy and Real Risks
- (2021) David S. Knopman et al. NEUROLOGY
- Revisiting FDA Approval of Aducanumab
- (2021) G. Caleb Alexander et al. NEW ENGLAND JOURNAL OF MEDICINE
- Approval of Aducanumab for Alzheimer Disease—the FDA’s Perspective
- (2021) Billy Dunn et al. JAMA Internal Medicine
- Medicare and the Shocking US Food and Drug Administration Approval of Aducanumab
- (2021) Francis J. Crosson et al. JAMA Internal Medicine
- Assessment of Expected Out-of-Pocket Spending for Rheumatoid Arthritis Biologics Among Patients Enrolled in Medicare Part D, 2010-2019
- (2020) Alexandra Erath et al. JAMA Network Open
- Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer’s Disease Neuroimaging Initiative
- (2020) Thomas K. Karikari et al. MOLECULAR PSYCHIATRY
- Estimates of the Association of Dementia With US Mortality Levels Using Linked Survey and Mortality Records
- (2020) Andrew C. Stokes et al. JAMA Neurology
- How Much Value Would a Treatment for Alzheimer’s Disease Offer? Cost-Effectiveness Thresholds for Pricing a Disease-Modifying Therapy
- (2020) Hankyung Jun et al. Current Alzheimer Research
- The Real-World Medicare Costs of Alzheimer Disease: Considerations for Policy and Care
- (2019) Bruce Pyenson et al. Journal of Managed Care & Specialty Pharmacy
- Frequency and longitudinal clinical outcomes of Alzheimer's AT(N) biomarker profiles: A longitudinal study
- (2019) Jin-Tai Yu et al. Alzheimers & Dementia
- Assessing cost-effectiveness of early intervention in Alzheimer's disease: An open-source modeling framework
- (2019) Colin Green et al. Alzheimers & Dementia
- In-hospital outcomes and 30-day readmission rates among ischemic and hemorrhagic stroke patients with delirium
- (2019) Farhaan S. Vahidy et al. PLoS One
- Value-Based Pricing for Drugs
- (2018) Anna Kaltenboeck et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Defining Elements of Value in Health Care—A Health Economics Approach: An ISPOR Special Task Force Report [3]
- (2018) Darius N. Lakdawalla et al. VALUE IN HEALTH
- Prevalence and Outcomes of Amyloid Positivity Among Persons Without Dementia in a Longitudinal, Population-Based Setting
- (2018) Rosebud O. Roberts et al. JAMA Neurology
- Dementia-Associated Mortality at Thirteen Years in the NEDICES Cohort Study
- (2018) Alberto Villarejo et al. JOURNAL OF ALZHEIMERS DISEASE
- Racial and ethnic estimates of Alzheimer's disease and related dementias in the United States (2015–2060) in adults aged ≥65 years
- (2018) Kevin A. Matthews et al. Alzheimers & Dementia
- How useful is the EQ-5D in assessing the impact of caring for people with Alzheimer’s disease?
- (2017) Catherine Reed et al. Health and Quality of Life Outcomes
- Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses
- (2016) Gillian D. Sanders et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Unknown
- (2016) ACTA PSYCHIATRICA SCANDINAVICA
- ACC/AHA Statement on Cost/Value Methodology in Clinical Practice Guidelines and Performance Measures
- (2014) Jeffrey L. Anderson et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Contribution of Alzheimer disease to mortality in the United States
- (2014) B. D. James et al. NEUROLOGY
- Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold
- (2014) Peter J. Neumann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Monetary Costs of Dementia in the United States
- (2013) Michael D. Hurd et al. NEW ENGLAND JOURNAL OF MEDICINE
- Measuring Alzheimer Disease Progression with Transition Probabilities: Estimates from NACC-UDS
- (2012) D. Eldon Spackman et al. Current Alzheimer Research
- How Cancer Patients Value Hope And The Implications For Cost-Effectiveness Assessments Of High-Cost Cancer Therapies
- (2012) Darius N. Lakdawalla et al. HEALTH AFFAIRS
- Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis
- (2012) Reisa Sperling et al. LANCET NEUROLOGY
- Predictors of costs of care in Alzheimer’s disease: A multinational sample of 1222 patients
- (2011) Anders Gustavsson et al. Alzheimers & Dementia
- Multicomponent Geriatric Intervention for Elderly Inpatients With Delirium: Effects on Costs and Health-Related Quality of Life
- (2011) K. H. Pitkala et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Staging Dementia Using Clinical Dementia Rating Scale Sum of Boxes Scores
- (2008) Sid E. O’Bryant ARCHIVES OF NEUROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More